• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖化 CD59 是妊娠期糖尿病的潜在生物标志物。

Glycated CD59 is a potential biomarker for gestational diabetes mellitus.

机构信息

Department of Endocrinology, The Affiliated Suqian Hospital of Xuzhou Medical University, Suqian, Jiangsu, China.

出版信息

Front Endocrinol (Lausanne). 2024 Sep 16;15:1374253. doi: 10.3389/fendo.2024.1374253. eCollection 2024.

DOI:10.3389/fendo.2024.1374253
PMID:39351537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11439654/
Abstract

OBJECTIVE

To explore the diagnostic value of glycated CD59 (gCD59) in gestational diabetes mellitus (GDM).

METHODS

A total of 707 pregnant women who underwent the first visit in the obstetric outpatient clinic of the Affliated Suqian Hospital of Xuzhou Medical University from January 2022 to July 2023 were included, and were grouped according to the International Association of the Diabetes and Pregnancy Study Groups(IADPSG) diagnostic criteria, and finally 113 cases in the GDM group and 559 cases in the normal glucose tolerance (NGT) group were included, and the concentration of gCD59 was determined by enzyme-linked immunosorbent assay (ELISA). The baseline data characteristics of the two groups were compared, the risk factors for GDM were explored by multivariate binary logistic analysis, and the diagnostic value of gCD59 in predicting GDM was explored by receiver operating characteristic (ROC) curve analysis.

RESULTS

The level of gCD59 in the GDM group was significantly higher than that in the NGT group (1.49 SPU vs 0.87 SPU). Multivariate regression analysis showed that gCD59, diastolic blood pressure (DBP) and thyroid stimulating hormone (TSH) were independent risk factors for GDM.The area under the curve (AUC) of gCD59 for the diagnosis of GDM was 0.681 (95% : 0.583-0.717), with a sensitivity of 71.7% and a specificity of 58.3%. In combination with fasting glucose, gCD59 effectively diagnosed GDM with higher AUC of 0.871 (95% : 0.708-1.000).

CONCLUSION

gCD59 is an independent risk factor for GDM and a good biomarker for the diagnosis of GDM.

摘要

目的

探讨糖化 CD59(gCD59)在妊娠期糖尿病(GDM)中的诊断价值。

方法

选取 2022 年 1 月至 2023 年 7 月在徐州医科大学附属宿迁医院妇产科门诊首次就诊的 707 例孕妇,根据国际妊娠合并糖尿病研究组织(IADPSG)诊断标准进行分组,最终纳入 GDM 组 113 例和正常糖耐量(NGT)组 559 例,采用酶联免疫吸附试验(ELISA)测定 gCD59 浓度。比较两组的基线资料特征,采用多因素二分类 Logistic 回归分析 GDM 的危险因素,采用受试者工作特征(ROC)曲线分析 gCD59 预测 GDM 的诊断价值。

结果

GDM 组 gCD59 水平显著高于 NGT 组(1.49 SPU 比 0.87 SPU)。多因素回归分析显示,gCD59、舒张压(DBP)和促甲状腺激素(TSH)是 GDM 的独立危险因素。gCD59 诊断 GDM 的曲线下面积(AUC)为 0.681(95%:0.583-0.717),灵敏度为 71.7%,特异度为 58.3%。与空腹血糖联合检测时,gCD59 诊断 GDM 的 AUC 有效提高至 0.871(95%:0.708-1.000)。

结论

gCD59 是 GDM 的独立危险因素,也是诊断 GDM 的良好生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/083d55c32554/fendo-15-1374253-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/2a51a695bd37/fendo-15-1374253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/c0149950e452/fendo-15-1374253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/24a88312a8c6/fendo-15-1374253-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/083d55c32554/fendo-15-1374253-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/2a51a695bd37/fendo-15-1374253-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/c0149950e452/fendo-15-1374253-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/24a88312a8c6/fendo-15-1374253-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1c10/11439654/083d55c32554/fendo-15-1374253-g004.jpg

相似文献

1
Glycated CD59 is a potential biomarker for gestational diabetes mellitus.糖化 CD59 是妊娠期糖尿病的潜在生物标志物。
Front Endocrinol (Lausanne). 2024 Sep 16;15:1374253. doi: 10.3389/fendo.2024.1374253. eCollection 2024.
2
Plasma glycated CD59 (gCD59), a novel biomarker for the diagnosis, management and follow up of women with Gestational Diabetes (GDM) - protocol for prospective cohort study.血浆糖化 CD59(gCD59)作为一种新型生物标志物,用于诊断、管理和随访妊娠糖尿病(GDM)妇女的前瞻性队列研究方案。
BMC Pregnancy Childbirth. 2020 Jul 18;20(1):412. doi: 10.1186/s12884-020-03090-9.
3
Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns.血浆糖化 CD59 预测早发型妊娠期糖尿病和巨大儿。
J Clin Endocrinol Metab. 2020 Apr 1;105(4):e1033-40. doi: 10.1210/clinem/dgaa087.
4
Glycation of the complement regulatory protein CD59 is a novel biomarker for glucose handling in humans.补体调节蛋白CD59的糖基化是人类葡萄糖代谢的一种新型生物标志物。
J Clin Endocrinol Metab. 2014 Jun;99(6):E999-E1006. doi: 10.1210/jc.2013-4232. Epub 2014 Mar 14.
5
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening.血浆糖化 CD59 在预测产后葡萄糖不耐受中的效用:在普遍的 GDM 筛查期间诊断为 GDM 的女性的前瞻性研究。
Diabet Med. 2023 Sep;40(9):e15121. doi: 10.1111/dme.15121. Epub 2023 May 2.
6
Plasma Glycated CD59, a Novel Biomarker for Detection of Pregnancy-Induced Glucose Intolerance.血浆糖化CD59,一种检测妊娠诱导性糖耐量异常的新型生物标志物。
Diabetes Care. 2017 Jul;40(7):981-984. doi: 10.2337/dc16-2598. Epub 2017 Apr 27.
7
A specific and sensitive assay for blood levels of glycated CD59: a novel biomarker for diabetes.一种针对糖化 CD59 血药浓度的特异且灵敏的检测方法:一种新型糖尿病生物标志物。
Am J Hematol. 2013 Aug;88(8):670-6. doi: 10.1002/ajh.23478. Epub 2013 Jun 20.
8
Early Assessment of the Risk for Gestational Diabetes Mellitus: Can Fasting Parameters of Glucose Metabolism Contribute to Risk Prediction?早期妊娠糖尿病风险评估:血糖代谢的空腹参数能否有助于风险预测?
Diabetes Metab J. 2019 Dec;43(6):785-793. doi: 10.4093/dmj.2018.0218. Epub 2019 Mar 12.
9
Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes.血浆糖化 CD59 预测妊娠期糖尿病产后葡萄糖不耐受。
Eur J Endocrinol. 2021 Oct 11;185(5):755-763. doi: 10.1530/EJE-21-0635.
10
First trimester prediction of gestational diabetes mellitus using plasma biomarkers: a case-control study.利用血浆生物标志物对妊娠糖尿病进行孕早期预测:一项病例对照研究。
J Perinat Med. 2019 Feb 25;47(2):161-168. doi: 10.1515/jpm-2018-0120.

引用本文的文献

1
Proteomic Profiling of Endothelial Cell Secretomes After Exposure to Calciprotein Particles Reveals Downregulation of Basement Membrane Assembly and Increased Release of Soluble CD59.钙磷蛋白颗粒暴露后内皮细胞分泌组的蛋白质组学分析显示,基底膜组装下调和可溶性 CD59 释放增加。
Int J Mol Sci. 2024 Oct 23;25(21):11382. doi: 10.3390/ijms252111382.

本文引用的文献

1
An early prediction model for gestational diabetes mellitus based on metabolomic biomarkers.基于代谢组学生物标志物的妊娠期糖尿病早期预测模型。
Diabetol Metab Syndr. 2023 Jun 1;15(1):116. doi: 10.1186/s13098-023-01098-7.
2
Effect of the interaction between advanced maternal age and pre-pregnancy BMI on pre-eclampsia and GDM in Central China.高龄产妇与孕前 BMI 对中国中部地区子痫前期和 GDM 的交互作用的影响。
BMJ Open Diabetes Res Care. 2023 Apr;11(2). doi: 10.1136/bmjdrc-2023-003324.
3
2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023.
2. 糖尿病的分类和诊断:2023 年糖尿病护理标准。
Diabetes Care. 2023 Jan 1;46(Suppl 1):S19-S40. doi: 10.2337/dc23-S002.
4
The Diagnostic Accuracy of Second Trimester Plasma Glycated CD59 (pGCD59) to Identify Women with Gestational Diabetes Mellitus Based on the 75 g OGTT Using the WHO Criteria: A Prospective Study of Non-Diabetic Pregnant Women in Ireland.孕中期血浆糖化CD59(pGCD59)基于世界卫生组织标准采用75克口服葡萄糖耐量试验(OGTT)诊断妊娠期糖尿病的诊断准确性:爱尔兰非糖尿病孕妇的前瞻性研究
J Clin Med. 2022 Jul 4;11(13):3895. doi: 10.3390/jcm11133895.
5
Gestational Diabetes Mellitus: Diagnostic Approaches and Maternal-Offspring Complications.妊娠期糖尿病:诊断方法及母婴并发症。
Diabetes Metab J. 2022 Jan;46(1):3-14. doi: 10.4093/dmj.2021.0335. Epub 2022 Jan 27.
6
Fasting plasma glucose level to guide the need for an OGTT to screen for gestational diabetes mellitus.空腹血糖水平指导 OGTT 的必要性,以筛查妊娠期糖尿病。
Acta Diabetol. 2022 Mar;59(3):381-394. doi: 10.1007/s00592-021-01812-9. Epub 2021 Nov 1.
7
Correlation Between High Serum Ferritin Level and Gestational Diabetes: A Systematic Review.高血清铁蛋白水平与妊娠期糖尿病之间的相关性:一项系统综述
Cureus. 2021 Oct 23;13(10):e18990. doi: 10.7759/cureus.18990. eCollection 2021 Oct.
8
A Comparison of Pregnancy Outcomes Using Two Diagnostic Criteria for Gestational Diabetes Mellitus-Carpenter Coustan Criteria and International Association of the Diabetes and Pregnancy Study Groups (IADPSG) Criteria.使用两种妊娠期糖尿病诊断标准(卡彭特-库斯坦标准和国际糖尿病与妊娠研究组(IADPSG)标准)对妊娠结局的比较
J ASEAN Fed Endocr Soc. 2017;32(1):27-31. doi: 10.15605/jafes.032.01.05. Epub 2017 Apr 12.
9
Gestational Diabetes Mellitus: A Harbinger of the Vicious Cycle of Diabetes.妊娠期糖尿病:糖尿病恶性循环的先兆。
Int J Mol Sci. 2020 Jul 15;21(14):5003. doi: 10.3390/ijms21145003.
10
Serum miR-195-5p is upregulated in gestational diabetes mellitus.血清miR-195-5p在妊娠期糖尿病中上调。
J Clin Lab Anal. 2020 Aug;34(8):e23325. doi: 10.1002/jcla.23325. Epub 2020 Apr 17.